Wanner, C., Cooper, M. E., Johansen, O. E., Toto, R., Rosenstock, J., McGuire, D. K., . . . Perkovic, V. (2021). Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: The CARMELINA randomized controlled trial. Clin Kidney J.
Citação norma ChicagoWanner, Christoph, et al. "Effect of Linagliptin Versus Placebo On Cardiovascular and Kidney Outcomes in Nephrotic-range Proteinuria and Type 2 Diabetes: The CARMELINA Randomized Controlled Trial." Clin Kidney J 2021.
Citação norma MLAWanner, Christoph, et al. "Effect of Linagliptin Versus Placebo On Cardiovascular and Kidney Outcomes in Nephrotic-range Proteinuria and Type 2 Diabetes: The CARMELINA Randomized Controlled Trial." Clin Kidney J 2021.